Related Experiment Video
Updated: May 3, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
The problem with concomitant atrial fibrillation in non-mitral valve surgery
Mark La Meir1, Sandro Gelsomino2, Bart Nonneman3
1Department of Cardiothoracic Surgery, University Hospital Brussels, Brussels, Belgium ; ; Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands ;
Insights
Treating atrial fibrillation (AF) during heart surgery lacks consensus due to limited trials and unclear benefits. A proposed epicardial ablation technique may offer a solution for restoring sinus rhythm.
Area of Science:
- Cardiovascular Surgery
- Cardiac Electrophysiology
Background:
- Atrial fibrillation (AF) affects approximately 10% of cardiac surgery patients.
- Current treatment strategies for concomitant AF during cardiac surgery lack universal agreement.
- The Maze procedure is often not favored in patients not requiring atriotomy due to perceived complexity.
Purpose of the Study:
- To review the challenges and lack of consensus in treating atrial fibrillation during cardiac surgery.
- To explore the limitations in evidence, particularly the absence of large randomized controlled trials (RCTs).
- To propose a novel surgical approach for AF management in this patient cohort.
Main Methods:
- Review of existing literature and clinical practices regarding AF treatment in cardiac surgery.
- Discussion of the limitations of current evidence, including the scarcity of multicenter RCTs.
- Presentation of a novel surgical technique: a total epicardial lesion set without incisions.
Main Results:
- Lack of consensus stems from insufficient high-quality evidence (RCTs) supporting rhythm restoration.
- Surgeons often perceive the Maze procedure as overly complex for patients not needing atriotomy.
- A significant gap exists in understanding AF pathology and optimal ablation strategies.
Conclusions:
- There is a critical need for robust evidence to guide AF treatment during cardiac surgery.
- A minimally invasive, total epicardial ablation approach is proposed as a potential solution.
- Further research and validation of new techniques are necessary to improve patient outcomes.
Abstract:
Treatment of atrial fibrillation (AF) in concomitant surgery is not unanimously agreed upon in the cardiac surgical community. The reason for this lack of consensus is threefold. Firstly, there is an absence of large multicenter randomized controlled trials (RCT) proving the benefit of restoring sinus rhythm in a patient population which we encounter almost daily (about 10% of cardiac surgery patients are diagnosed with AF). Secondly, for patients undergoing cardiac surgery without the need for an atriotomy, the Maze procedure is not widely accepted. In these patients, many surgeons do not think that the increased complexity outweighs the potential future benefits of sinus rhythm. Thirdly, due to our limited understanding of this pathology, we are confronted with many choices of ablation tools and lesion sets. In this perspective these issues are reviewed. As a possible solution, a total epicardial lesion set without any incisions is proposed.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction

